MARKET

MIRA

MIRA

Mira Pharma
NASDAQ
0.9400
-0.0200
-2.08%
Pre Market: 0.9408 +0.0008 +0.09% 04:05 06/15 EDT
OPEN
0.9601
PREV CLOSE
0.9600
HIGH
0.9791
LOW
0.9357
VOLUME
689
TURNOVER
0
52 WEEK HIGH
2.450
52 WEEK LOW
0.9000
MARKET CAP
39.50M
P/E (TTM)
-0.6519
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MIRA last week (0608-0612)?
Weekly Report · 3h ago
Psychedelic: Optimi Health completes psilocybin export to the UK
TipRanks · 3d ago
MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer
TipRanks · 6d ago
Mira Pharmaceuticals Appoints Andriy Mushak As Fractional CFO Following Departure Of CFO Alan Weichselbaum, Effective June 6, 2026
Benzinga · 6d ago
MIRA PHARMACEUTICALS - APPOINTS ANDRIY MUSHAK AS FRACTIONAL CFO EFFECTIVE JUNE 6, 2026 - SEC FILING
Reuters · 6d ago
Weekly Report: what happened at MIRA last week (0601-0605)?
Weekly Report · 06/08 09:36
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
TipRanks · 06/04 15:00
MIRA Pharmaceuticals Secures Unified Global Rights to Pipeline
TipRanks · 06/04 12:35
More
About MIRA
MIRA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics for neurologic, neuropsychiatric, and metabolic disorders. The Company's pipeline includes oral drug candidates designed to address significant unmet medical needs in neuropathic pain, inflammatory pain, obesity, addiction, anxiety, and cognitive decline. It holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2 and MIRA-55, two novel drug candidates designed to address unmet medical needs in neuropathic and inflammatory pain, as well as neuropsychiatric and neurocognitive disorders. Its pipeline also includes SKNY-1, a next-generation oral therapy candidate for obesity and smoking cessation. Ketamir-2 is a patent-pending oral ketamine analog evaluated for the treatment of diabetic neuropathy and is in an ongoing Phase I clinical trial.

Webull offers Mira Pharmaceuticals Inc stock information, including NASDAQ: MIRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRA stock methods without spending real money on the virtual paper trading platform.